Evaluation of anticonvulsant activity of N-(p-aminobenzoyl)-1,2,3,4-tetrahydro-4-methylquinoline

Authors

  • B Tantisira
  • C Patarapanich
  • MH Tantisira
  • S Rodpaewpaln
Abstract:

Anticonvulsant activity of N-(p-aminobenzoyl)-1,2,3,4-tetrahydro-4-methylquinoline (NMQ), a newly synthesized ameltolide analogue, was investigated with regards to efficacy, lethality and neurotoxicity in mice. In vivo microdialysis experiments on freely moving rats were also performed in search for the possible effect of NMQ on cortical amino acid neurotransmitters. Similar to ameltolide, intraperitoneally given NMQ exerted it protective effect exclusively in maximal electroshock seizure (MES), but not in pentylenetetrazole test. However, in comparison with ameltolide which exhibited the median effective dose (ED50) of 1.08 mg/kg body weight (B.W.), NMQ was less effective (ED50 = 77.62 mg/kg B.W.). Based on the finding that no lethality was observed in mice being given NMQ up to 1000 mg/kg B.W. while the median lethality dose (LD50) of ameltolide was observed at 63 mg/kg B.W., NMQ appeared to be superior to ameltolide with regards to safety. The median neurotoxic dose (TD50) from the rotarod test was found to be 320 and 9 mg/kg B.W. for NMQ and ameltolide respectively, resulting in lower protective index (PI=TD50/ED50) of NMQ (4.12) than that of ameltolide (8.33). Thus, it could be anticipated that therapeutic dose of NMQ which seemed to be safe would produce more pronounced motor impairment than that of ameltolide. In microdialysis study on freely moving rats, it was found out that neither NMQ nor ameltolide was able to exert significant changes on the level of cortical brain amino acid neurotransmitters, namely, aspartate, glutamate, glycine and GABA. Therefore, some mechanisms other than alteration in brain amino acid neurotransmitters should underlie anticonvulsant activity exhibited by these two compounds in MES test. Furthermore, based on similarity in pharmacological screening profile of NMQ and ameltolide observed in the present study, it is suggestive that these two compounds may possess rather similar mechanism of action.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Preclinical evaluation of anticonvulsant activity of N-(p-aminobenzoyl)-1,2,3,4-tetrahydroquinoline

Anticonvulsant activity of N-(p-aminobenzoyl)-1,2,3,4- tetrahydro-quinoline (NTQ), a newly synthesized ameltolide analog, was investigated with regards to efficacy and toxicity in mice. Additionally, its effect on NMDA receptors was also performed on NR1a/NR2B expressed in Xenopus oocytes. NTQ, given intraperitoneally, was able to protect the animals in both maximal electroshock seizure and pen...

full text

Preclinical evaluation of anticonvulsant activity of N-(p-aminobenzoyl)-1,2,3,4-tetrahydroquinoline

Anticonvulsant activity of N-(p-aminobenzoyl)-1,2,3,4- tetrahydro-quinoline (NTQ), a newly synthesized ameltolide analog, was investigated with regards to efficacy and toxicity in mice. Additionally, its effect on NMDA receptors was also performed on NR1a/NR2B expressed in Xenopus oocytes. NTQ, given intraperitoneally, was able to protect the animals in both maximal electroshock seizure and pen...

full text

Synthesis and Anticonvulsant Activity Evaluation of 3-alkoxy-4-(4- (hexyloxy/heptyloxy)phenyl)-4H-1,2,4 -triazole

A series of 3-alkoxy-4-(4-(hexyloxy/heptyloxy) phenyl)-4H-1,2,4-triazole was synthesized. The anticonvulsant effect and neurotoxicity of the compounds were calculated with maximal electroshock (MES) test and rotarod tests with intraperitoneally injected mice. Among the synthesized compounds, compound 3-heptyloxy-4-(4-(hexyloxy) phenyl)-4H-1,2,4-triazole (5f) was the most active one and also had...

full text

Synthesis and Anticonvulsant Activity Evaluation of 3-alkoxy-4-(4- (hexyloxy/heptyloxy)phenyl)-4H-1,2,4 -triazole

A series of 3-alkoxy-4-(4-(hexyloxy/heptyloxy) phenyl)-4H-1,2,4-triazole was synthesized. The anticonvulsant effect and neurotoxicity of the compounds were calculated with maximal electroshock (MES) test and rotarod tests with intraperitoneally injected mice. Among the synthesized compounds, compound 3-heptyloxy-4-(4-(hexyloxy) phenyl)-4H-1,2,4-triazole (5f) was the most active one and also had...

full text

Evaluation of the anticonvulsant activity of terpinen-4-ol.

Terpinen-4-ol is a monoterpenoid alcohol and component of the essential oils of several aromatic plants. Similarly to terpinen-4-ol, other monoterpenoid alcohols have shown anticonvulsant activity in convulsion animal models. The present study aimed to investigate the anticonvulsant activity of terpinen-4-ol. Treatment of mice with terpinen-4-ol (200 mg/kg) caused a significant decrease in the ...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume Volume 3  issue Supplement 1

pages  23- 23

publication date 2010-11-20

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023